Literature DB >> 2665156

Immunomodulating therapy in experimental myocarditis.

A Matsumori1, C Kawai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2665156     DOI： 10.1007/bf00197087

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  37 in total

1.  Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy.

Authors:  R E Fowles; C P Bieber; E B Stinson
Journal:  Circulation       Date:  1979-03       Impact factor: 29.690

Review 2.  Levamisole in the modulation of the immune response: the current experimental and clinical state.

Authors:  J Symoens; M Rosenthal
Journal:  J Reticuloendothel Soc       Date:  1977-03

3.  Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy.

Authors:  B Maisch; P Deeg; G Liebau; K Kochsiek
Journal:  Am J Cardiol       Date:  1983-11-01       Impact factor: 2.778

4.  Immunosuppressive agents in renal transplantation.

Authors:  T B Strom
Journal:  Kidney Int       Date:  1984-09       Impact factor: 10.612

5.  Protective effect of interferon on infections with hand, foot, and mouth disease virus in newborn mice.

Authors:  O Sasaki; T Karaki; J Imanishi
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

6.  An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice.

Authors:  A Matsumori; C Kawai
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

7.  Human leukocyte interferon produced by E. coli is biologically active.

Authors:  D V Goeddel; E Yelverton; A Ullrich; H L Heyneker; G Miozzari; W Holmes; P H Seeburg; T Dull; L May; N Stebbing; R Crea; S Maeda; R McCandliss; A Sloma; J M Tabor; M Gross; P C Familletti; S Pestka
Journal:  Nature       Date:  1980-10-02       Impact factor: 49.962

8.  Inhibition of human IL 2 production by MDP and derivatives.

Authors:  C Leclerc; A Morin; E Deriaud; L Chedid
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

9.  Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens.

Authors:  S A Huber; P A Lodge
Journal:  Am J Pathol       Date:  1984-07       Impact factor: 4.307

10.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.

Authors:  I Gresser; M G Tovey; M E Bandu; C Maury; D Brouty-Boyé
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307
View more
  4 in total

Review 1.  [Therapy of dilated cardiomyopathies with and without inflammation].

Authors:  G Hufnagel; S Pankuweit; B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

Review 2.  An approach to the treatment of pediatric myocarditis.

Authors:  Daniel Levi; Juan Alejos
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 3.  Innovative drug treatments for viral and autoimmune myocarditis.

Authors:  S Anandasabapathy; W H Frishman
Journal:  J Clin Pharmacol       Date:  1998-04       Impact factor: 3.126

4.  Diagnosis and management of viral myocarditis.

Authors:  William H Frishman; Joshua Zeidner; Nauman Naseer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.